Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Evotec completes acquisition of Central Glass Germany
Friday, November 04, 2022Evotec SE announced today that the acquisition of Central Glass Germany GmbH from the Japanese chemical manufacturing company Central Glass Co Ltd signed in August has been completed As Evotec Drug Substance Germany GmbH Evotec DS the strategic tran...
Amneal Receives FDA Approval for Leuprolide Acetate Injection
Thursday, November 03, 2022Amneal Pharmaceuticals Inc announced that it has received Abbreviated New Drug Application ANDA approval from the US Food and Drug Administration FDA for leuprolide acetate for injection Harsher Singh SVP for Amneal Biosciences stated We are making t...
Novo Holdings acquires KabaFusion
Thursday, November 03, 2022Novo Holdings acquires KabaFusion from Pritzker Private Capital KabaFusions clinicianled management team will remain significant investors in the business alongside Novo Holdings Novo Holdings a leading healthcare investment firm announced today its...
CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology
Wednesday, November 02, 2022CSL Limited announces that its subsidiary CSL Seqirus has entered into a collaboration and license agreement with Arcturus Therapeutics Holdings Inc Arcturus Therapeutics to access their late stage selfamplifying mRNA samRNA vaccine platform technolo...
Exelixis and Cybrexa Therapeutics Establish Exclusive Collaboration Providing Exelixis the Right to Acquire CBX-12, a Potential First-in-Class Peptide-Drug Conjugate of Exatecan
Wednesday, November 02, 2022Exelixis Inc and Cybrexa Therapeutics announced that the companies have entered into an exclusive collaboration agreement providing Exelixis the right to acquire CBX alphalex exatecan a clinicalstage firstinclass peptidedrug conjugate PDC that utiliz...
Thermo Fisher Scientific to Acquire The Binding Site Group
Tuesday, November 01, 2022Thermo Fisher Scientific Inc the world leader in serving science today announced that it has entered into a definitive agreement to acquire The Binding Site Group The Binding Site a global leader in specialty diagnostics from a shareholder group led...
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
Tuesday, November 01, 2022Biofrontera Inc a biopharmaceutical company specializing in the commercialization of dermatological products announced today it has entered into private exchange agreements with certain holders of options to acquire ordinary shares of Biofrontera AG...
InnoCare Announces First Adolescent Patient Dosed in Clinical Trial of pan-TRK Inhibitor ICP-723 in China
Monday, October 31, 2022InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases announced today that the first adolescent patient has been dosed in clinical trial with its second generation panTRK inhibitor ICP at the...
Thermo Fisher Scientific to Expand Clinical Research Laboratory in Kentucky
Friday, October 28, 2022The PPD clinical research business of Thermo Fisher Scientific Inc the world leader in serving science today announced plans to invest million to significantly expand its laboratory operations in Highland Heights Kentucky helping customers deliver l...
PTC Therapeutics Announces Strategic Financing Collaboration with Blackstone with up to $1 Billion in Funding
Friday, October 28, 2022PTC Therapeutics Inc announced that it has entered into a strategic financing collaboration with funds managed by Blackstone NYSE BX to support its mission to reach a steadystate of delivering at least one therapy every years to continue to bring tr...
